VIDEO - Future is bio-pharma: Kiran Mazumdar-Shaw
Biocon's executive chairperson Dr Kiran Mazumdar Shaw, calls for a PLI scheme specially focused on incentivising biopharma investment.
biopharmaceuticals
September 2021
July 2021
April 2018
Syngene’s winning formula
Syngene International was started by Biocon in 1993 to provide research services for pharma companies. Three decades later, the entity wants to become a global science company in its own right.
Biocon’s net profit up marginally
Its net profit rose by 2% to Rs 130 crore from Rs 127 crore a year ago, representing a net profit margin of 11%.
